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Hypertension needs to be adequately controlled to reduce cardiovascular events and mortality [1–4]. Lifestyle modification should be used to
prevent mild hypertension and to reduce the dose levels of drugs needed to control hypertension. Weight reduction, consuming a diet rich in
fruits, vegetables, and low-fat dairy products with less saturated fat and
total fat, sodium reduction to not exceed 1.5 g daily, smoking cessation,
regular aerobic physical activity, avoidance of excessive alcohol intake,
avoidance of excessive caffeine, and avoidance of drugs which can increase blood pressure, including nonsteroidal anti-inflammatory drugs,
glucocorticoids, and sympathomimetics, are recommended [4, 5]. Implementing a national salt reduction program is a simple and cost-effective
way of improving public health [6, 7].
Long-term observational follow-up was performed in 744 persons in
the first phase of the Trials of Hypertension Prevention (TOHP I) (10 years
after its end) and in 2,382 persons in TOHP II (5 years after its end),
in which persons with prehypertension were randomized to sodium reduction or to a usual diet (25–35% greater sodium intake) [8]. In these
studies, sodium reduction reduced cardiovascular events by 25%. At
31-month follow-up of 1,981 Taiwanese veterans living in a retirement
home, older men randomized to a potassium-enriched diet with 50%
less sodium had a 41% decrease in cardiovascular mortality compared
with those randomized to a regular salt diet [9].
At 14.8-year follow-up of 12,267 adults in the Third National Health
and Nutrition Examination Survey, a higher sodium intake was associated
with a 20% increase in all-cause mortality per 1,000 mg of sodium intake
per day, whereas a higher potassium intake was associated with a 20% reduction in mortality per 1,000 mg of potassium intake per day [10]. For the
sodium-potassium ratio, compared with the lowest quartile, the highest
quartile increased all-cause mortality by 46%, cardiovascular mortality by
46%, and ischemic heart disease mortality by 215% [10]. A meta-analysis
of 56 randomized controlled trials showed a mean blood pressure reduction of 3.7/0.9 mm Hg for a 100 mmol/day reduction in sodium excretion
[11]. Current guidelines suggest no more than 2,300 mg of sodium daily in
the general population and no more than 1,500 mg of sodium daily in
older persons, in blacks, and in persons with hypertension, diabetes mellitus, chronic kidney disease, or heart failure [12].
A one-third decrease in dietary sodium intake in Finland was associated with a decrease in blood pressure and a 75% to 80% decrease
in both coronary heart disease and stroke mortality [13]. Data from the
Health Survey for England included 9183 persons in 2003, 8762 persons in 2006, 8974 persons in 2008, and 4753 persons in 2011 [14].
From 2003 to 2011, salt intake measured by 24-hour urinary sodium
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was 1.9 g less per day, blood pressure in persons
not taking antihypertensive medication was lower
by 2.7/1.1 mm Hg, mortality from stroke was 42%
lower, and mortality from ischemic heart disease
was 40% lower [14]. A meta-analysis of 34 trials
including 3230 persons showed that sodium reduction reduced blood pressure by 5.39/2.82 mm
Hg in persons with hypertension [15]. A modeling
study demonstrated that 1.65 million cardiovascular deaths in 2010 were caused by sodium consumption above a reference level of 2 g/day [16].
Reduction of dietary sodium intake by lowering
sodium content in processed food and by not adding salt to food would lead to a lower blood pressure and to a decrease in cardiovascular events
and mortality. A national salt reduction program is
one of the simplest and most cost-effective ways
of improving public health.
Other lifestyle measures in treating prehypertension and hypertension include weight control, smoking cessation, aerobic physical activity, reduction in
dietary fat and cholesterol, adequate dietary potassium, calcium, and magnesium intake, avoidance
of excessive alcohol intake (no more than 1 ounce
daily in men and half an ounce daily in women and
light-weight men), avoidance of excessive caffeine,
and avoidance of drugs which increase blood pressure such as nonsteroidal anti-inflammatory drugs,
sympathomimetics, glucocorticoids, etc. [4, 5].
The body mass index should be maintained between 18.5 and 24.9 kg/m2 [4, 5]. A meta-analysis
of 25 randomized, controlled trials including 4874
persons showed that a weight reduction of 5.1 kg
by means of reduction of caloric intake, increased
physical activity, or both, reduced the blood pressure by 4.44/3.57 mm Hg [17].
The Dietary Approaches to Stop Hypertension
(DASH) diet is rich in fruits, vegetables, and lowfat dairy products with a decreased content of saturated and total fat [18, 19]. In 459 persons with
blood pressures of <160/80–95 mm Hg, compared
with a control diet, the DASH diet reduced blood
pressure by 5.5/3.0 mm Hg more than the control
diet [18]. In 412 persons, compared with a control diet with a high sodium content, the DASH
diet with a low sodium content reduced systolic
blood pressure by 11.5 mm Hg in persons with hypertension and by 7.1 mm Hg in persons without
hypertension [19].
A meta-analysis of 33 randomized controlled
trials including 2609 persons in which potassium
supplementation was the only difference between
the intervention and control groups demonstrated
that potassium supplementation in the diet reduced blood pressure by 3.11/1/97 mm Hg [20].
Another meta-analysis of 22 randomized controlled trials including 1606 persons showed that
increased potassium intake in the diet reduced
blood pressure by 3.49/1.96 mm Hg [21]. A me-
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ta-analysis of 11 cohort studies including 127,038
persons showed that increased potassium in the
diet reduced stroke by 24%, insignificantly reduced cardiovascular disease by 12%, and did not
affect the incidence of coronary heart disease [21].
A meta-analysis of 40 randomized controlled
trials including 2492 persons showed that calcium supplementation in the diet by a mean daily
dose of 1200 mg reduced blood pressure by 1.86/
0.99 mm Hg [22]. Magnesium supplementation
in the diet has also been shown to cause a small
reduction in blood pressure [23]. A meta-analysis of 40 randomized controlled trials including
3,277 persons showed that partially replacing dietary carbohydrate with increased dietary protein
reduced blood pressure by 2.27/1.26 mm Hg for
vegetable protein and 2.54/0.95 mm Hg for animal protein [24]. A meta-analysis of 25 randomized controlled trials showed that increased intake
of dietary fiber may reduce blood pressure in persons with hypertension [25]. A meta-analysis of
7 randomized controlled trials comprising 9 treatment arms and including 587 patients showed
that the dietary flavonol quercetin reduced blood
pressure by 3.04/2.63 mm Hg [26]. With quercetin doses of ≥ 500 mg/day, quercetin reduced
blood pressure by 4.45/2.98 mm Hg. There was
no significant effect for blood pressure reduction
for doses of quercetin less than 500 mg/day [26].
A meta-analysis of 54 randomized controlled
trials including 2419 persons showed that aerobic exercise reduced blood pressure by 3.84/
2.58 mm Hg [27]. Aerobic exercise reduced blood
pressure in persons with and without hypertension
and in overweight and in normal-weight persons
[27]. A meta-analysis of 93 trials involving 105 endurance exercise trials, 29 dynamic resistance exercise trials, 14 combined exercise trials, and 5 isometric resistance exercise trials including 5223 persons
(3401 exercise participants and 1822 control participants) showed that endurance exercise reduced
blood pressure by 3.5/2.5 mm Hg, dynamic resistance
exercise reduced blood pressure by 1.8/3.2 mm Hg,
and isometric resistance reduced blood pressure by
10.9/6.2 mm Hg [28]. Combined training reduced
diastolic blood pressure by 2.2 mm Hg. Endurance
exercise reduced systolic blood pressure more in persons with hypertension (8.3 mm Hg) than in prehypertensive persons (2.1 mm Hg) [28].
A meta-analysis of 15 randomized controlled
trials including 2234 persons showed that alcohol
reduction reduced blood pressure by 3.31/2.04 mm
Hg [29]. Alcohol reduction is recommended for the
prevention and treatment of hypertension [4, 5, 29].
Sodium reduction, weight loss, increased
physical activity, and limited alcohol intake are
established lifestyle measures to reduce blood
pressure. The DASH diet also reduces blood pressure. A study was performed in 4 clinical centers
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which included 810 persons, mean age 50 years
(62% women and 34% blacks) with above optimal
blood pressure not taking antihypertensive drugs
[30]. In this study, 268 persons were randomized
to established lifestyle measures, 269 persons
to established lifestyle measures plus the DASH
diet, and 273 persons to an advice control group.
After subtracting the reduction in blood pressure
from the advice group, the mean net reduction in
systolic blood pressure was 3.7 mm Hg with established lifestyle measures and 4.3 mm Hg with
established lifestyle measures plus the DASH diet.
At 6-month follow-up, the prevalence of a systolic
blood pressure below 120/80 mm Hg was 19% in
the advice group, 30% in the established lifestyle
measures group, and 35% in the established lifestyle measures plus DASH diet group [30].
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